Diagnostic Enzymes & IVD Reagents
Uric Acid Assay Enzyme Solutions
Uricase-based reagent systems for serum and plasma uric acid measurement, supplied in liquid or lyophilized formats with defined specific activity and supporting documentation.
What Uricase Assays Measure
Uric acid is the end product of purine metabolism in humans, and its concentration in serum or plasma is a routine clinical chemistry measurement. Enzymatic uric acid assays use uricase (urate oxidase) to oxidize uric acid to allantoin, hydrogen peroxide, and carbon dioxide. Because the reaction consumes uric acid directly, the assay is specific for the analyte rather than relying on nonspecific chemical reduction.
In commercial diagnostic formats, the hydrogen peroxide generated by the uricase step is quantified through a coupled peroxidase reaction. A Trinder-type chromogen is oxidized to produce a colored product whose absorbance is proportional to the uric acid concentration in the sample. This two-enzyme cascade is the basis of many automated clinical chemistry and plate-based uric acid assays.
For reagent developers and IVD manufacturers, the practical question is not whether the chemistry works, but whether the enzyme reagent delivers consistent activity, low background, and stable performance across lots and formulation formats. Our uric acid assay enzyme solutions are built around those reagent-level requirements.
Uricase Oxidation Step
Uricase catalyzes the oxidation of uric acid to allantoin with release of hydrogen peroxide, providing the analyte-specific first step of the assay.
- Defined specific activity, commonly specified at ≥5 U/mg
- Microbial recombinant uricase suitable for reagent formulation
- Compatible with serum and plasma sample matrices
Coupled Peroxidase Readout
The hydrogen peroxide produced by uricase is measured through a peroxidase-coupled chromogen system, giving a signal proportional to uric acid concentration.
- Trinder-type chromogen chemistry for colorimetric readout
- Adaptable to spectrophotometric plate or analyzer formats
- Fluorometric detection options where the assay format requires it
Reagent-Grade Documentation
Enzyme lots are supplied with documentation that supports reagent qualification and traceability in an IVD development workflow.
- Certificate of Analysis for each supplied lot
- Liquid and lyophilized formulation options
- Bulk quantities for reagent manufacturing
Where These Reagents Fit
Uricase-based enzyme solutions support several stages of diagnostic reagent development, from early feasibility work through to bulk reagent supply. The table below outlines typical application areas and what each one generally requires from the enzyme reagent.
Because assay formats, analyzer platforms, and sample types vary between programs, the specific activity, buffer system, and presentation format are confirmed against the project requirements rather than applied as a single fixed configuration.
| Application Area | Typical Format | Enzyme Requirement | Supporting Documentation |
|---|---|---|---|
| Clinical chemistry uric acid testing | Automated analyzer, liquid reagent | Uricase with defined specific activity and low lot-to-lot variation | Certificate of Analysis, activity data |
| Gout and hyperuricemia monitoring | Serum or plasma, colorimetric readout | Uricase compatible with coupled peroxidase/chromogen detection | Certificate of Analysis, formulation notes |
| Plate-based research assays | Microplate, spectrophotometric or fluorometric | Uricase supplied in a format suited to small-volume reactions | Certificate of Analysis, handling guidance |
| Lyophilized reagent kits | Dry or reconstituted kit format | Uricase compatible with lyophilization and reconstitution | Certificate of Analysis, stability-relevant data as scoped |
How Engagement Works
Engagement follows a reagent-development sequence: define the assay requirement, qualify the enzyme, confirm the detection chemistry, and then scale supply. Each stage produces information that feeds the next, so formulation decisions are made against measured performance rather than assumption.
Assay Requirement Review
We review the intended sample matrix, analyzer or plate format, expected measuring range, and whether the reagent will be supplied as a liquid or lyophilized component.
Enzyme Selection and Qualification
A uricase reagent with defined specific activity is selected for the program, and activity is confirmed against the project's acceptance criteria before formulation work begins.
Detection System Configuration
The coupled peroxidase and Trinder-type chromogen system is configured so that the hydrogen peroxide generated by uricase produces a signal proportional to uric acid concentration.
Calibration and QC Verification
Calibrators and controls are used to verify quantitation, and known uric acid standards are run to confirm that the reagent system performs within the defined acceptance range.
Customization Options
Uric acid assay programs differ in sample type, analyzer platform, and reagent presentation, so the enzyme solution is configured case by case. The options below describe what can be adjusted; the specific configuration is agreed during the project review.
Customization is not limited to the enzyme itself. Buffer composition, stabilizers, and the relationship between the uricase reagent and the detection components all influence assay performance and are treated as part of the same formulation discussion.
Liquid and Lyophilized Presentation
Uricase can be supplied as a liquid reagent or in a lyophilized format, depending on the stability profile and reconstitution requirements of the intended kit.
- Liquid formulation for automated analyzer reagents
- Lyophilized format for kit-based products
- Presentation selected against the project's stability requirements
Defined Specific Activity
Enzyme lots are characterized by specific activity, commonly specified at ≥5 U/mg, so that reagent loading can be calculated against the assay's required reaction rate.
- Specific activity stated on the Certificate of Analysis
- Activity confirmed against project acceptance criteria
- Consistent characterization across supplied lots
Bulk and OEM Supply
The enzyme is available in bulk quantities for reagent manufacturing, with OEM options for customers who need the reagent integrated into their own product format.
- Bulk quantities for reagent production
- OEM options for custom formulation
- Certificate of Analysis with each lot
Service Scope
The scope below describes the parameters that can be defined for a uric acid assay enzyme program. Values are agreed case by case during the project review and recorded in the project scope; they are not fixed package configurations.
Where a parameter depends on the customer's analyzer, kit format, or regulatory pathway, the scope is set against those requirements rather than applied as a default.
| Parameter | Typical Project Scope | Confirmation Point | Deliverable |
|---|---|---|---|
| Enzyme specific activity | Defined activity, commonly specified at ≥5 U/mg | Activity confirmed against project acceptance criteria | Certificate of Analysis |
| Reagent presentation | Liquid or lyophilized, as scoped | Selected against stability and reconstitution requirements | Formulated enzyme reagent |
| Detection chemistry | Coupled peroxidase with Trinder-type chromogen | Configured for the intended readout format | Detection system configuration notes |
| Sample compatibility | Serum and plasma; other matrices as scoped | Confirmed against the intended sample type | Compatibility documentation as scoped |
| Calibration and controls | Calibrators and controls for uric acid quantitation | Verified with known uric acid standards | QC verification record |
| Supply format | Bulk quantities; OEM options as scoped | Agreed against reagent manufacturing volume | Bulk enzyme with Certificate of Analysis |
Why Reagent Developers Work With Us
Reagent development programs need an enzyme supplier who can speak to activity, formulation, and documentation in the same conversation. Our uric acid assay enzyme solutions are positioned around that requirement, with the enzyme, the coupled detection chemistry, and the supporting documentation treated as one deliverable.
The result is a reagent component that can move from feasibility evaluation into bulk supply without a change in the underlying enzyme characterization.
Characterized Enzyme Lots
Each lot is characterized by specific activity and supplied with a Certificate of Analysis, so reagent loading and performance can be tracked across batches.
- Specific activity stated per lot
- Certificate of Analysis with each shipment
- Documentation suitable for reagent traceability
Formulation Support
Liquid and lyophilized formats are both supported, and the formulation is matched to the intended kit or analyzer platform rather than supplied as a single fixed configuration.
- Liquid reagent for analyzer platforms
- Lyophilized format for kit products
- OEM formulation options as scoped
From Evaluation to Bulk
The same enzyme chemistry supports early feasibility work and bulk reagent manufacturing, reducing the need to re-qualify a different reagent later in the program.
- Bulk quantities for reagent production
- Consistent characterization across scales
- Supply documentation aligned to reagent manufacturing
Assay Performance Considerations
Enzymatic uric acid measurement depends on the interaction between the uricase step and the coupled detection chemistry. The table below summarizes the parameters that are typically reviewed when qualifying a uricase-based reagent system.
These parameters are evaluated against the customer's own acceptance criteria and sample types; the values achieved depend on the specific assay configuration and are confirmed during the project.
| Parameter | What It Affects | Typical Review Approach | Documentation |
|---|---|---|---|
| Uricase specific activity | Reaction rate and reagent loading | Confirmed against project acceptance criteria | Certificate of Analysis |
| Peroxidase coupling efficiency | Signal proportionality to uric acid concentration | Evaluated with calibrators and known standards | QC verification record |
| Sample matrix effects | Accuracy in serum, plasma, or other matrices | Assessed against the intended sample type | Compatibility documentation as scoped |
| Reagent stability | Performance over the product shelf life | Evaluated in the selected liquid or lyophilized format | Stability-relevant data as scoped |
Documentation and Traceability
Reagent qualification depends on documentation as much as on enzyme performance. Each supplied lot is accompanied by a Certificate of Analysis that records the characterization data relevant to the reagent's use in a uric acid assay.
Where a program requires additional documentation to support its own development or regulatory activities, the requirement is discussed during the project review and reflected in the project scope.
Getting Started
To scope a uric acid assay enzyme program, share the intended sample matrix, the analyzer or plate format, the expected measuring range, and whether the reagent will be liquid or lyophilized. Those details determine the enzyme activity, formulation, and documentation package.
A named scientific contact is assigned at project start, with milestone review calls and email response within one business day for technical questions.
FAQ
What specific activity is available for the uricase reagent?
Uricase is supplied with a defined specific activity, commonly specified at ≥5 U/mg, and the activity is stated on the Certificate of Analysis for each lot. If a program requires a different activity specification, that requirement is reviewed during project scoping and confirmed against the intended assay format.
Can the enzyme be used with a Trinder-type colorimetric detection system?
Yes. The uricase reaction generates hydrogen peroxide, which is quantified through a coupled peroxidase reaction with a Trinder-type chromogen to produce a colorimetric signal proportional to uric acid concentration. The detection system is configured against the customer's intended readout format, whether that is a plate reader or an automated analyzer.
Is the reagent compatible with serum and plasma samples?
Uricase-based uric acid assays are commonly used with serum and plasma, and the reagent is configured for the sample matrix specified in the project. Other biological matrices can be evaluated as part of the scope, with sample preparation requirements such as deproteinization confirmed against the intended sample type.
What is the difference between the liquid and lyophilized formats?
Liquid formulation is typically used for automated analyzer reagents, while the lyophilized format suits kit-based products that require reconstitution. The choice depends on the stability profile and handling requirements of the intended product, and the appropriate format is selected during the project review rather than applied as a default.
What documentation is provided with bulk supply?
Bulk enzyme is supplied with a Certificate of Analysis covering the characterization data relevant to uric acid assay reagent use. Where a program needs additional documentation to support its own development or regulatory activities, that requirement is discussed during scoping and reflected in the project scope.
Are OEM and custom formulation options available?
OEM options and custom formulation are available and are defined case by case against the customer's product format. Buffer composition, stabilizers, and the relationship between the uricase reagent and the detection components are all part of the formulation discussion, and the agreed configuration is recorded in the project scope.
References
- Petitgas C, Seugnet L, Dulac A, et al. Metabolic and neurobehavioral disturbances induced by purine recycling deficiency in Drosophila. eLife. 2024;12. View on PubMed
- Wu Y, Sun X, Jia Y, et al. Therapeutic effect and mechanism of gigantol on hyperuricemia. Frontiers in endocrinology. 2025;16:1474808. View on PubMed
- Zhang M, Hussain A, Hu B, et al. Atavistic strategy for the treatment of hyperuricemia via ionizable liposomal mRNA. Nature communications. 2024;15(1):6463. View on PubMed
- Liu Y, Zhou Z, Jarman JB, et al. Gut bacteria degrade purines via the 2,8-dioxopurine pathway. Nature microbiology. 2025;10(9):2291-2305. View on PubMed
Scope Your Uric Acid Assay Enzyme Program
Share your sample matrix, analyzer or plate format, expected measuring range, and preferred reagent presentation. We will confirm the enzyme activity, formulation, and documentation package against your assay requirements.